CAS RN: 1108603-35-5
2-[(4R)-4,5-dihydro-4-(phenylMethyl)-2-oxazolyl]- Pyridine
Product Availability
Choose a grade to view its available package options.
5 package records4 with current stock2 grade groups
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20250505 |
100mg / 250mg / 1g / 5g |
Out of stock |
| 5-7 business days | Inquiry |
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20250418 |
100mg |
In stock |
Shanghai | | Inquiry |
| Batchno.20260308 |
1g |
In stock |
Tianjin, Chengdu | | Inquiry |
| Batchno.20250609 |
250mg |
In stock |
Shanghai, Shenzhen, Chengdu | | Inquiry |
| Batchno.20251202 |
5g |
In stock |
Tianjin | | Inquiry |
-
Product code:
starshine_CAS1108603-35-5
-
Purity/Analytical Methods:
>99.0%
GET A QUOTE
1108603-35-5 / (4R)-4-benzyl-2-pyridin-2-yl-4,5-dihydro-1,3-oxazole
4-benzyl-2-pyridin-2-yl-4,5-dihydro-1,3-oxazole | 2-(2-Pyridyl)-4-benzyl-2-oxazoline | 2-[(4S)-4-benzyl-4,5-dihydro-1,3-oxazol-2-yl]pyridine
Standard CAS: 1108603-35-5
Multi CAS: Yes
Basic Information
CAS
1108603-35-5
Multi CAS
Yes
Molecular Formula
C15H14N2O
Molecular Weight
238.280000
Exact Mass
238.110613
SMILES
C1[C@H](N=C(O1)C2=CC=CC=N2)CC3=CC=CC=C3
InChI
InChI=1S/C15H14N2O/c1-2-6-12(7-3-1)10-13-11-18-15(17-13)14-8-4-5-9-16-14/h1-9,13H,10-11H2/t13-/m1/s1
InChIKey
KDASQLQVBBTNJT-CYBMUJFWSA-N
Synonyms
4-benzyl-2-pyridin-2-yl-4,5-dihydro-1,3-oxazole
2-(2-Pyridyl)-4-benzyl-2-oxazoline
2-[(4S)-4-benzyl-4,5-dihydro-1,3-oxazol-2-yl]pyridine
2-(4-Benzyl-4,5-dihydro-1,3-oxazol-2-yl)pyridine
SCHEMBL15842376
Computed Properties
Structural Parameters
Heavy atom count
18
Aromatic heavy atom count
12
Fraction Csp3
0.2
Rotatable bonds
3
H-bond acceptors
3
Molar refractivity
70.66
TPSA
34.48
LogP / Solubility
WLOGP
2.47
MLOGP
2.18
XLogP3
2.7
Consensus LogP
2.45
Log S (ESOL)
-3.17
Class (ESOL)
Poorly soluble
Log S (Ali)
-3.3
Class (Ali)
Poorly soluble
Log S (SILICOS-IT)
-3.62
Class (SILICOS-IT)
Poorly soluble
ADME
GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-2.42
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
2